← Top stories
Legal▼ Bearish for Fortis Healthcare
Supreme Court allows independent forensic audit of Fortis transactions in Daiichi dispute
The brief
- The Supreme Court declined to interfere with Delhi High Court orders allowing the audit
- The dispute is linked to a ₹3,500 crore arbitral award in Daiichi Sankyo’s favour
- Audit scrutiny may affect Fortis Healthcare investors and the company’s governance outlook
| Stock | Traded | That day | vs Nifty | Volume | Since |
|---|---|---|---|---|---|
| FORTIS | Fri, 25 Sept | −4.5% | −4.8% | 2.4× | −4.5% · Nifty +0.3% |
✓ Classifier read this as negative; FORTIS fell 4.8% against the Nifty on the day it traded.
Fortis forensic audit in Daiichi dispute
The Supreme Court declined to interfere with Delhi High Court orders allowing a forensic audit of Fortis transactions in the Daiichi–Singh Brothers dispute. Fortis says it is not involved in the dispute and is confident the audit will support its position.
Sunday, 27 September
Friday, 25 September
- Supreme Court allows independent forensic audit of Fortis transactions in Daiichi dispute